NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP
Molina Healthcare, Inc. MOH
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$45.4B
▲ 11.7% vs FY2024
EPS · FY25
$8.92
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
11.0%
Net margin · FY25
1.0%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 45.4B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
1 cents of every revenue dollar became profit this year.
Per share
USD 8.92
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
11.0%
Return on equity, FY2025
ROE
Operating margin1.7%
Net margin1.0%
Return on assets3.0%
Each USD of equity produced 11 cents of profit this year.
Returned to shareholders
USD 1.0B
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 1.0B
Share of profit211.9%
Consecutive raises—
USD 1.0B in buybacks — 212% of the year's profit, so the payout drew on cash built up earlier.
Growth
+18.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+12.4%
+18.5%
+12.3%
+17.4%
Net income
−15.8%
−6.8%
+12.7%
+15.4%
EPS, diluted
−13.0%
−4.5%
+13.2%
+13.6%
Returned to shareholders
+35.7%
+10.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.05B
Shares outstanding, FY2025
Change, 5 years−13.6%
Change, 10 years−8.9%
The share count shrank 14% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 15.6B
total assets, end of FY2025
Total assetsUSD 15.6B
EquityUSD 4.1B
CashUSD 4.2B
Gross debtUSD 3.8B
Net debtUSD -482.0M
Current ratio1.69×
The company holds more cash than debt.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
45.4
40.6
34.1
32.0
27.8
19.4
16.8
18.9
19.9
17.8
14.2
9.7
6.6
5.9
4.5
4.1
3.7
Operating income $B
0.8
1.7
1.6
1.2
1.0
1.1
1.0
1.1
−0.6
0.3
0.4
0.2
0.1
0.0
0.1
0.1
0.1
EBITDA $B
1.0
1.9
1.7
1.3
1.2
1.2
1.1
1.3
−0.4
0.5
0.5
0.3
0.2
0.1
0.2
0.2
0.1
Income tax $B
0.1
0.4
0.4
0.3
0.2
0.3
0.2
0.3
−0.1
0.2
0.2
0.1
0.0
0.0
0.0
0.0
0.0
Net income $B
0.5
1.2
1.1
0.8
0.7
0.7
0.7
0.7
−0.5
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
EPS, diluted $
8.92
20.42
18.77
13.55
11.25
11.23
11.47
10.61
−9.07
0.92
2.58
1.29
1.13
0.21
0.45
1.32
0.79
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
11.0
27.1
30.4
28.3
27.9
33.2
40.9
47.4
−34.3
3.2
11.1
6.5
6.3
1.3
2.8
7.6
·
Shares out B
0.05
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.05
0.05
0.05
0.05
0.05
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed